Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „Mounjaro“
Suchtreffer
Begriffe & Kennungen
Mounjaro · 4.8 · In pooled placebo-controlled weight management phase 3 studies, the overall incidence of cholecystitis and cho
Eintrag öffnenMounjaro · 4.8 · In the weight management phase 3 studies, acute gallbladder events were positively associated with weight redu
Eintrag öffnenMounjaro · 4.8 · Injection site reactions
Eintrag öffnenMounjaro · 4.8 · More patients in the tirzepatide 5 mg (1.9 %), 10 mg (4.4 %) and 15 mg (4.1 %) groups compared to the placebo
Eintrag öffnenMounjaro · 4.8 · More patients in the tirzepatide 5 mg (3.0 %), 10 mg (5.4 %) and 15 mg (6.6 %) groups compared to the placebo
Eintrag öffnenMounjaro · 4.8 · No severe hypoglycaemic episodes occurred during the paediatric T2DM trial. During the placebo- controlled pha
Eintrag öffnenMounjaro · 4.8 · Paediatric Population
Eintrag öffnenMounjaro · 4.8 · Pancreatic enzymes
Eintrag öffnenMounjaro · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenMounjaro · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenMounjaro · 4.8 · Small mean increases in PR interval were observed with tirzepatide when compared to placebo (mean increase of
Eintrag öffnenMounjaro · 4.8 · Summary of safety profile
Eintrag öffnenMounjaro · 4.8 · System organ Very common Common Uncommon Rare class Immune Hypersensitivity Anaphylactic system reactions reac
Eintrag öffnenMounjaro · 4.8 · Table 1. Adverse reactions
Eintrag öffnenMounjaro · 4.8 · Tabulated list of adverse reactions
Eintrag öffnenMounjaro · 4.8 · The following related adverse reactions from clinical studies are listed below by system organ class and in or
Eintrag öffnenMounjaro · 4.8 · The percentage of patients who had a change of baseline heart rate of > 20 bpm for 2 or more consecutive visit
Eintrag öffnenMounjaro · 4.8 · The rate of clinically significant hypoglycaemia when tirzepatide was used as monotherapy or when added to oth
Eintrag öffnenMounjaro · 4.8 · The safety and immunogenicity profiles in children and adolescents aged 10 to less than 18 years with T2DM tre
Eintrag öffnenMounjaro · 4.8 · There was no evidence of an altered pharmacokinetic profile or an impact on efficacy of tirzepatide associated
Eintrag öffnen